Public attitudes diverge sharply on legal use of psychedelics
Mental Health Weekly March 2, 2026 DOI: 10.1002/mhw.34775 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | News report Peer reviewed |
|---|---|
| Key points | The RAND research report indicates that 23% of respondents support legal psilocybin mushrooms, compared with 65% for cannabis, while support for legal LSD and MDMA-assisted therapy is near 10%. |
Abstract
Support for the legal use of psilocybin mushrooms (23%) is much lower than it is for cannabis (65%), according to a new RAND research report, released Feb. 24. For LSD and 3,4‐methylenedioxymethamphetamine (MDMA)–assisted therapy, support for legal use is closer to 10%.